Evidence map›Paper›PMID 31041876›Full record

ArticleMolecular pain

A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy.

Matthew Alsaloum, Mark Estacion, Rowida Almomani, Monique M Gerrits, Gidon J Bönhof, Dan Ziegler, Rayaz Malik, Maryam Ferdousi, Giuseppe Lauria, Ingemar Sj Merkies and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Diabetic neuropathy: cutting-edge research and future directions.Signal transduction and targeted therapy · 2025
    Review
  6. Genetic Variants Influence the Development of Diabetic Neuropathy.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Peripheral Ion Channel Genes Screening in Painful Small Fiber Neuropathy.International journal of molecular sciences · 2022
    Article
  11. iPSCs and DRGs: stepping stones to new pain therapies.Trends in molecular medicine · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 8 countries.

Matthew Alsaloum1 Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-9832-0138
Mark Estacion1 Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Rowida Almomani4 Department of Clinical Genomics, University Medical Center Maastricht, Maastricht, the Netherlands.
Monique M Gerrits4 Department of Clinical Genomics, University Medical Center Maastricht, Maastricht, the Netherlands.
Gidon J Bönhof7 Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
Dan Ziegler7 Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
Rayaz Malik10 Weill Cornell Medicine-Qatar, Doha, Qatar.
Maryam Ferdousi11 Division of Diabetes, Endocrinology and Gastroenterology, Institute of Human Development, University of Manchester, Manchester, UK.
Giuseppe Lauria12 Neuroalgology Unit, IRCCS Foundation "Carlo Besta" Neurological Institute, Milan, Italy.
Ingemar Sj Merkies6 Department of Neurology, University Medical Centre Maastricht, Maastricht, the Netherlands.
Catharina G Faber6 Department of Neurology, University Medical Centre Maastricht, Maastricht, the Netherlands.
Sulayman Dib-Hajj1 Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Stephen G Waxman1 Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Propane Study Group
Veterans Health Administration · USMaastricht University Medical Centre · NLDeutsches Diabetes-Zentrum e.V. · DEUniversity of Manchester · GBJordan University of Science and Technology · JOUniversity of Milan · IT

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Diabetes mellitus is a global challenge with many diverse health sequelae, of which diabetic peripheral neuropathy is one of the most common. A substantial number of patients with diabetic peripheral neuropathy develop chronic pain, but the genetic and epigenetic factors that predispose diabetic peripheral neuropathy patients to develop neuropathic pain are poorly understood. Recent targeted genetic studies have identified mutations in α-subunits of voltage-gated sodium channels (Na

Indexed as

Action PotentialsDiabetic NeuropathiesGain of Function MutationGanglia, SpinalHEK293 CellsHumansIon Channel GatingNeuralgiaOpen Reading FramesProtein DomainsTetrodotoxinVoltage-Gated Sodium Channel beta SubunitsTetrodotoxinVoltage-Gated Sodium Channel beta SubunitsDiabetic neuropathyneuropathic painsodium channel beta-subunitsvoltage-gated sodium channels

Identifiers

PMID31041876
PMCPMC6510061
OpenAlexW2943510885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.